---
title: "Adaptive Biotechnologies (ADPT) Gets a Buy from Piper Sandler"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/296800637.md"
description: "Piper Sandler analyst David Westenberg maintained a Buy rating on Adaptive Biotechnologies (ADPT) with a $27.50 price target. Westenberg, a 5-star analyst in the Healthcare sector, has an 18.7% average return. The broader market consensus for ADPT is also a Strong Buy, with an average price target of $25.07."
datetime: "2026-08-24T14:05:16.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/296800637.md)
  - [en](https://longbridge.com/en/news/296800637.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/296800637.md)
generator: "portal-rs"
---

# Adaptive Biotechnologies (ADPT) Gets a Buy from Piper Sandler

Piper Sandler analyst David Westenberg maintained a Buy rating on Adaptive Biotechnologies today and set a price target of $27.50.

### Summer Sale - Claim 70% Off TipRanks

-   Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions
-   Subscribe to TipRanks Smart Investor Newsletter, and discover new investing opportunities with data-backed stock picks

According to TipRanks, Westenberg is a 5-star analyst with an average return of 18.7% and a 57.56% success rate. Westenberg covers the Healthcare sector, focusing on stocks such as Natera, Waters, and Veracyte.

The word on The Street in general, suggests a Strong Buy analyst consensus rating for Adaptive Biotechnologies with a $25.07 average price target.

### Related Stocks

- [ADPT.US](https://longbridge.com/en/quote/ADPT.US.md)
- [PIPR.US](https://longbridge.com/en/quote/PIPR.US.md)
- [NTRA.US](https://longbridge.com/en/quote/NTRA.US.md)
- [WAT.US](https://longbridge.com/en/quote/WAT.US.md)
- [VCYT.US](https://longbridge.com/en/quote/VCYT.US.md)

## Related News & Research

- [Adaptive Biotechnologies (ADPT) Rebound Keeps Fair Value In Focus](https://longbridge.com/en/news/298158136.md)
- [Algert Global LLC Has $2.83 Million Position in Adaptive Biotechnologies Corporation $ADPT](https://longbridge.com/en/news/297395406.md)
- [TD Cowen Keeps Their Buy Rating on Amgen (AMGN)](https://longbridge.com/en/news/298357051.md)
- [Adaptive Biotechnologies (ADPT), Why Is It Getting Fresh Attention Now?](https://longbridge.com/en/news/297264786.md)
- [TPG’s Asia OneHealthcare said to confidentially file for US$2.5 billion IPO](https://longbridge.com/en/news/297874967.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**